Recap of Q&A Online Chat after the Webcast (Part 3)
Jordan Huck (06/06/2013 12:15:04 PM):I was reading about titanium-graphene composites being tested at Oak Ridge laboratories. Will your 3D machine being developed with IMI be capable of using those materials when they become available? Have any of the partners you have worked with in the past expressed interest in your quality assurance processes being suitable for use with those graphene strengthened compounds for aerospace, etc.?
Vivek Dave (06/06/2013 12:16:27 PM):Graphenes are still an early stage material with significant challenges in scaleup and mass production. That being said they do of course offer tremendous potential properties advantages. Our system would be applicable to basically any 3D printing system from which we can extract physically meaningful sensor data
Kevin Alford (06/06/2013 12:16:50 PM):Nice presentation. thanks
Vivek Dave (06/06/2013 12:17:03 PM):Thank you we appreciate your interest
Harit RC (06/06/2013 12:18:00 PM):Do you have anything to add about the Osseoset Dental Implant system ?
Vivek Dave (06/06/2013 12:18:56 PM):We are seeking commercialization partners who could address the FDA qualification requirements and the 510K filing requirements. We will discuss more as specific details become available
Oscar Orozco (06/06/2013 12:19:25 PM):Can you provide some insight into how current and near term agreements will affect earnings for 2013?
Robert Greene (06/06/2013 12:20:54 PM):What is your # 1 need at this moment? Getting more cash into the company? Signing more contracts?
Mark Cola (06/06/2013 12:21:48 PM):We have definite revenue plans in place for 2013 and 2014. We anticipate a transition into a recurring revenue model as we focus on 3D printing moving into 2014.